The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
Lei Xu(Queen Mary University of London), Yong‐Jie Lu(Queen Mary University of London), Pui Ying Chan(Barts Health NHS Trust), Jonathan Shamash(Queen Mary University of London), Greg Shaw(University College Hospital), Tianyu Guo(Electric Power Research Institute), Yuqin Wang(Kunming Medical University), Amar Ahmad(Queen Mary University of London), Elzbieta Stankiewicz(Queen Mary University of London), Daniel M. Berney(Queen Mary University of London), R.T.D. Oliver(University of Cambridge), Xueying Mao(Ministry of Education), John Hines(Barts Health NHS Trust)
Cited by 85
Related Papers
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
|The Lancet|2005|447
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334
Cancer incidence in the United Kingdom: projections to the year 2030
|British Journal of Cancer|2011|284
Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960
|British Journal of Cancer|2015|273